Eastwood Bio-Medical Canada Inc. (TSXV:EBM)
Canada · Delayed Price · Currency is CAD 1.900
+0.020 (1.06%)
Sep 4, 2026, 3:59 PM EST
TSXV:EBM Balance Sheet
Financials in millions CAD. Fiscal year is November - October.
Millions CAD. Fiscal year is Nov - Oct.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 30, 2026 | Oct '25 Oct 31, 2025 | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 |
Cash & Equivalents | 0.01 | 0.02 | - | 0.02 | 0.04 | 0.02 |
Cash & Short-Term Investments | 0.01 | 0.02 | - | 0.02 | 0.04 | 0.02 |
Cash Growth | -52.33% | - | - | -53.69% | 90.91% | -82.99% |
Accounts Receivable | 0.09 | 0.01 | 0.04 | 0.01 | 0.01 | 0.01 |
Other Receivables | - | - | - | 0.07 | - | - |
Receivables | 0.09 | 0.01 | 0.04 | 0.08 | 0.01 | 0.01 |
Prepaid Expenses | 0 | 0 | 0 | 0.05 | 0.05 | 0.03 |
Total Current Assets | 0.1 | 0.03 | 0.04 | 0.15 | 0.1 | 0.06 |
Property, Plant & Equipment | 0.16 | 0.19 | 0.23 | 0.34 | 0.45 | 0.55 |
Other Long-Term Assets | - | - | - | - | 0.04 | 0.08 |
Total Assets | 0.27 | 0.22 | 0.27 | 0.49 | 0.58 | 0.69 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 30, 2026 | Oct '25 Oct 31, 2025 | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 |
Accounts Payable | 1.74 | 0.08 | 0.08 | 1.16 | 0.78 | 0.71 |
Short-Term Debt | 0.07 | 0.08 | 0.08 | 0.06 | 0.03 | - |
Current Unearned Revenue | 0.01 | 0.01 | 0.02 | 0.07 | 0.02 | 0.02 |
Other Current Liabilities | 0.17 | 1.67 | 1.4 | 0.03 | 0.02 | 0.07 |
Total Current Liabilities | 1.98 | 1.85 | 1.57 | 1.33 | 0.84 | 0.8 |
Long-Term Debt | - | - | - | - | 0.03 | 0.03 |
Total Liabilities | 1.98 | 1.85 | 1.57 | 1.33 | 0.88 | 0.84 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 30, 2026 | Oct '25 Oct 31, 2025 | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 |
Common Stock | 4.69 | 4.69 | 4.69 | 4.69 | 4.69 | 4.69 |
Retained Earnings | -6.41 | -6.33 | -5.99 | -5.54 | -4.99 | -4.84 |
Comprehensive Income & Other | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
Shareholders' Equity | -1.72 | -1.63 | -1.3 | -0.84 | -0.29 | -0.14 |
Total Liabilities & Equity | 0.27 | 0.22 | 0.27 | 0.49 | 0.58 | 0.69 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 30, 2026 | Oct '25 Oct 31, 2025 | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 |
Total Debt | 0.07 | 0.08 | 0.08 | 0.06 | 0.06 | 0.03 |
Net Cash (Debt) | -0.06 | -0.06 | -0.08 | -0.04 | -0.02 | -0.01 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
Filing Date Shares Outstanding | 68.89 | 68.89 | 68.89 | 68.89 | 68.89 | 68.89 |
Total Common Shares Outstanding | 68.89 | 68.89 | 68.89 | 68.89 | 68.89 | 68.89 |
Working Capital | -1.88 | -1.82 | -1.53 | -1.18 | -0.74 | -0.75 |
Book Value Per Share | -0.02 | -0.02 | -0.02 | -0.01 | -0.00 | -0.00 |
Tangible Book Value | -1.72 | -1.63 | -1.3 | -0.84 | -0.29 | -0.14 |
Tangible Book Value Per Share | -0.02 | -0.02 | -0.02 | -0.01 | -0.00 | -0.00 |
Machinery | 0.32 | 0.32 | 0.32 | 0.32 | 0.22 | 0.32 |
Leasehold Improvements | 0.22 | 0.22 | 0.22 | 0.22 | - | - |